| |
| |
|
|
 |
|
| |
Architektur Bau- & Umwelttechnik Belletristik Betriebswirtschaft Biologie Briefe, Bewerbung, Rhetorik Chemie Entspannung & Meditation Esoterik & Anthroposophie Essen und Trinken Fitness, Aerobic, Bodybuilding, Gymnastik Garten, Pflanzen, Natur Geowissenschaften Geschenkbücher Geschichte Gesundheit, Körperpflege Heimwerken Hobby, Freizeit, Natur Informatik & EDV Innenarchitektur & Design Journalistik & Presse Kinder- & Jugendliteratur Kunst Lebensführung Literaturwissenschaft Lyrik, Dramatik, Essays Management Mathematik Mechanik & Akustik Medien & Kommunikation Medizin & Pharmazie Musik Nachschlagewerke Naturmedizin & Homöopathie Naturwissenschaft & Technik Partnerschaft, Beziehungen Pädagogik Philosophie Physik & Astronomie Politik, Gesellschaft, Arbeit Psychologie Recht Reise Religion Romane, Erzählungen & Anthologien Sachbuch / Ratgeber Schule & Lernen Soziologie Sport Sprachwissenschaft Steuern Technik Theater, Ballett & Film Tiere Tiermedizin Umwelt, Land- & Forstwirtschaft Verlagswesen, Buchhandel, Bibliothekswesen Völkerkunde & Volkskunde Werbung & Marketing Wirtschaft |
|
| |
|
 |
|
| |
Design, Architektur & bildende Kunst Aktuelle Buchempfehlungen |
|
|
 |
|
| |
|
|
| |
|
|
|
|
| |
|
| |
|
 |
|
| |
Redaktion: S. Serge Barold, Philippe Ritter
Devices for Cardiac Resynchronization
Technologic and Clinical Aspects
erschienen Dezember 2007 527 Seiten, 260 illus., 20 in color, 33 tab., Gebunden
Springer-Verlag GmbH | ISBN: 038771166x
| |  | 123.00 EUR |  | | |
|
|
|
|
| |
Innerhalb 24 Stunden versandfertig. Expressversand: In Deutschland versandkostenfrei | Österreich: 4 € | Schweiz: ab 4 € | Europaweit ab 6 €. Versandkostenübersicht weltweit. Alle Preise inkl. MwSt. |
|
|
Ähnliche Bücher anzeigen
|
|
|
| |
| |
| VORWORT | öffnen |
|
PrefaceThe last of an ongoing series of Cardiostim monographs all devoted to cardiac pacing, was published four years ago. Since then, cardiac resynchronization for the treatment of heart failure has undergone spectacular progress and has revolutionized device therapy. Many patients have benefited from ventricular resynchronization often combined with an implantable cardioverter-defibrillator. More implantations are likely in the future as the indications continue to evolve with more attention b...
[weiter lesen]
|
|
|
| KLAPPENTEXT | öffnen |
|
The treatment of congestive heart failure by implanted biventricular pacemakers, or cardiac resynchronization therapy, has revolutionized the practice of implanting pacemakers and defibrillators. More cardiac resynchronization therapy devices than conventional pacemakers are now being implanted and their numbers are growing worldwide. This comprehensive volume will be useful to cardiologists, cardiac electrophysiologists, cardiac surgeons, cardiology fellows in training, intensive care speciali... [weiter lesen] |
|
|
| AUTOR | öffnen |
|
S. Serge Barold, MD, FRACP, FACP, FACC, FESC, FHRS Clinical Professor of Medicine University of South Florida College of Medicine and Division of Cardiology Tampa General Hospital Tampa, Florida, USA Philippe Ritter, MD Chairman Cardiostim InParys, St. Cloud Clinique Bizet, Paris Clinique Chirurgicale Val d'Or St. Cloud, Paris, France List of ContributorsChristine Alonso, MD InParys, St Cloud Clinique Bizet, Paris Clinique Chirurgicale Val d'Or St Cloud, France Juan M. Aranda, Jr., MD A... [weiter lesen] |
|
|
| INHALTSVERZEICHNIS | öffnen |
Table of Contents Preface ix List of Contributors xi Section I Indications and Implantation for Cardiac Resynchronization Therapy Chapter 1. Do the Official Guidelines for Cardiac Resynchronization Therapy Need to B... Nadim G Khan, Anne B. Curtis, Bengt Herweg, and S. Serge Barold Chapter 2. Alternative Techniques for Left Ventricular Lead Placement 17 Shane Bailey and Bruce L. Wilkoff Chapter 3. Importance of the Right Ventricular Pacing Site in Cardiac Resynchronizati... Gael Jauvert, Christine Alonso, Serge Cazeau, Arnaud Lazarus, and Philippe Ritter Chapter 4. Alternative Means of Achieving Cardiac Resynchronization 35 Michael O. Sweeney Chapter 5. CRT-Pacing Only Versus CRT-Defibrillator 63 Arthur J. Moss Chapter 6. Upgrading Conventional Pacemakers to CRT: Indications and Technical Consid... Safwat A. Gassis and Angel R. Leon Section II Cardiac Resynchronization for Heart Failure Chapter 7. Update of Cardiac Resynchronization Trials 95 S. Serge Barold and Bengt Herweg Chapter 8. Cardiac Resynchronization for Heart Failure: Do We Need More Trials? 105 Sunil T. Mathew, Christina M. Murray, and Dwight W. Reynolds Chapter 9. Should Cardiac Resynchronization Be Considered for the Prevention of Heart... I. Eli Ovsyshcher and S. Serge Barold Chapter 10. Left Bundle Branch Block-Induced Cardiomyopathy: A New Concept of Mechani... Jean-Jacques Blanc, Marjaneh Fatemi, Philippe Castellant, and Yves Etienne Chapter 11. Role of Echocardiography Before CRT Implantation: Can We Predict Nonrespo... Gabe B. Bleeker, Nico van der Veire, Martin J. Schalij, and Jeroen J. Bax Chapter 12. Role of Echocardiography After Implantation of a Cardiac Resynchronizatio... Serge Cazeau, Stéphane Garrigue, Stéphane Laffitte, Philippe Ritter, and S.... Section III Advances in Technology Chapter 13. Recent Advances in the Technology of Cardiac Resynchronization Therapy ... Carsten W. Israel and S. Serge Barold Chapter 14. Advances in Left Ventricular Pacing Leads 203 Luigi Padeletti Chapter 15. New Pacing Algorithms and Functions in CRT Devices 213 Roland X. Stroobandt, Alfons F. Sinnaeve, and S. Serge Barold Chapter 16. Significance of Latency During Left Ventricular Pacing for Cardiac Resync... Bengt Herweg, Arzu Ilerc il, Chris Madramootoo, Nadim G Khan, and S. Serge Barold Chapter 17. Programmability of the Interventricular Interval During Cardiac Resynchro... S. Serge Barold, Arzu Ilercil, and Bengt Herweg Chapter 18. Hemodynamic Sensors in Heart Failure Devices 253 Chu-Pak Lau and Hung-Fat Tse Chapter 19. Assessment of Single-Shock Defibrillation Testing of Biventricular ICDs ... B. Judson Colley and Michael R Gold Section IV Follow-up Chapter 20. How to Program CRT Devices 283 Christophe Leclercq, Oliver Césari, Philippe Mabo, and J. Claude Daubert Chapter 21. Programming and Follow-up of CRT and CRTD Devices 317 Michael O. Sweeney Chapter 22. The Standard Electrocardiogram During Cardiac Resynchronization 425 S. Serge Barold, Michael Giudici, and Bengt Herweg Chapter 23. Cardiac Arrhythmias After Cardiac Resynchronization 457 S. Serge Barold and Bengt Herweg Chapter 24. Advances in CRT Device Diagnostics 475 Jeffrey Wing-Hong Fung and Cheuk-Man Yu Chapter 25. Complex Issues in the Follow-up of CRT Devices 495
[weiter lesen] |
|
|
|
|
| REGISTER | öffnen |
Index AActivity sensor, 258 - See also Hemodynamic sensors Afterdepolarizations, 351 Alerts (CRT advances), patient, 196-198 Algorithms - CRT-related, 188 AF, 192-193 atrial refractory sensing, 189, 191-192 atrial tachyarrhythmia therapies, 194-196 AV and VV delay, automatic optimization of, 193 - LVCM, 193 ventricular resynchronization restoration in special situations, 192-193 - ventricular triggered mode, 193 - defibrillation testing, 270-272 - pacing, 213-223 Angiography, shepherd's hook, 42 Anodal capture, defined, 336 - See also LV capture; RV capture Anodal stimulation, 249, 444-448 Anode-limited battery, 181 Antibradycardia pacing, CRT and, 129 - See also Pacing Antitachycardia pacing (ATP) after CRT, 470 atrial, 194 - CRT-related algorithms, 194 - ventricular therapies programming in CRTD, 353-354 - See also Atrial fibrillation (AF); Ventricular tachyarrhythmias APAF trial, 11 Apical RV pacing, 28-30 - See also LV pacing Apnea, 187 Arrhythmias AF, 457-458, 498-501 after CRT, 457-170 atrial, 298-302, 498-501 - ventricular, 499, 501-502 Atrial arrhythmias, 298-302, 498-501 - See also Antitachycardia pacing (ATP); Atrial fibrillation (AF); Atrial tachyarrhyt... Atrial fibrillation (AF), 9-11 after CRT, 457-458 - chronic pacing requiring, CRT upgrade and, 73-74 - CRT and, 113 - device memory functions, 186 - devices programming aspects, 298-306 - impact of AF incidence, 457-458 - issues and, 498-501 - loss aspects, 361-366 - paroxysmal, 298-302 - permanent, 302-307 - RV pacing after AV nodal ablation for, 129-130 - ventricular resynchronization restoration in special situations, 192-193 - V-V programming in patients with permanent, 244 - See also Antitachycardia pacing (ATP); Defibrillation threshold testing (DFT); Vent... - See also Atrial undersensing; Nonresponders; Ventricular oversensing Atrial pacing ... - CRT nonresponders management and, 394-398 - noncompetitive (NCAP), 300 - rate modulated single-chamber (AAIR), 70 - single-chamber (A AI), 70 - See also Antitachycardia pacing (ATP); Biventricular pacing; Ventricular pacing Atr... Atrial refractory (AR) period, 189, 191-192 Atrial sensing late (intraatrial conduction delay), 444 - oversensing, 359-360, 393 - refractory sensing, 189, 191-192 - undersensing, 393 - See also Ventricular sensing Atrial shocks, 195 Atrial tachyarrhythmias - with rapid ventricular conduction, 360-366 - See also Atrial arrhythmias; Ventricular tachyarrhythmias therapies, 194-196 Atrial tachycardia (AT), 300 - See also Ventricular tachycardia (VT) Atrial tracking recovery algorithm, 191 Atrial undersensing, 355, 393 - See also Atrial oversensing Automatic adjusting sensitivity (AAS) sensing, 379 Automatic device-based optimization, V-V delay and, 249 Automatic gain control (AGC) sensing, 379 Automatic left ventricular threshold - measurement, 213-217 Automatic optimization, 193, 217-220, 222-223 - See also AV optimization Automatic sensitivity control, 312 - See also Ventricular tachycardia (VT) AV (atrioventricular) - nodal ablation for AF, 129-130 - programmability, 246 - resynchronization, 171-173 AV block (AVB), 9-10, 355, 441-442 AV conduction - correction, 322-327 - CRT loss aspects, 361-362, 365 - LV pacing for, 322-327 - prolonged, 322-327 - test, 215 - See also Ventricular fusion beats with native conduction AV delay automatic optimization, 193, 217-219, 222-223 - CRT device programming and, 496-497 - CRT nonresponders management and, 395-398 - during exercise, 289 - echocardiography after CRT implantation and, 171-173 - optimal, 219, 246 - programming, 291-293 - prolonged, 318 - See also Ventricular conduction delay; VV delay AV dyssynchrony, 148, 167 - See also Interventricular dyssynchrony AV interval, 254, 256, 343 - See also AV delay; V-V interval AV optimization, 217, 219-220, 322-327, 340-345 BBattery (CRT device hardware technology), 181-182 Bifocal RV pacing, see Dual site RV pacing BIOPACE study, 10 - See also CRT trials Bipolar leads, 330, 379 - See also LV lead placement Biventricular ATP, 353-354 Biventricular capture, 284-288 - See also LV capture; RV capture Biventricular devices, 269, 290, 294-295 - See also Biventricular Pacemakers; - Implanted cardioverter defibrillator (ICD) Biventricular pacemakers - anodal stimulation in, 444-448 - CRT electrocardiogram during, 444-452 - electrocardiogram during CRT and, 429, 433-438 - electrocardiographic follow-up of, 285-288 - interventricular V-V timing effect on ECG of, 448-452 Biventricular pacing, 30-31 - defibrillation testing in, 274-275 - monochamber RV pacing upgrading to, 30-31 - upgrading to triple ventricular pacing, 30-31 - with conventional DDD pacemaker, 453 - See also Atrial pacing Biventricular stimulation, 346-350, 411-412 - See also Stimulation BLOCK HF trial, 10 Buddy wire technique, 42 - See also LV pacing CCannulation, CS ostium, 38 Cardiac resynchronization, defined, 322 - See also CRT Cardiac surgical approach for LV lead - placement, 52-55 Cardiomyopathy, 139-144 - See also under Dilated cardiomyopathy (DCM) CARE-HF trial, 3, 5, 8, 95-102, 105-106 - atrial arrhythmias and, 498 - atrial fibrillation and CRT, 113 - benefits from CRT, 108 CRT-D versus CRT-P study, 63-64 - extension phase of, 100-101 - ICD versus CRT and, 112 - if CRT without ICD reduce all-cause mortality but not sudden death?, 459 - mortality and, 101-102, 110 - NYHA classes, 118 - QRS duration and morphology in CRT, 114 - recurrent HF and, 511 - ventricular tachyarrhythmias after CRT, 459 - See also CRT trials Catheters (LV leads advances), guiding, 204-207 Cathode-limited battery, 181 Central venous oxygen saturation, 260-261 - See also Hemodynamic sensors Chronic pacing requiring atrial fibrillation patients, CRT upgrade and, 73-74 Clinical practice guidelines, CRT, 4 Color-coded TDI, 153-155 - See also Pulsed-wave TDI COMPANION trial, 3, 5, 63-64, 95-97, 101-102, 105-106, 108... - See also CRT trials Competitive atrial pacing, 300-301 Conduction delay, 442 - See also AV delay Conduction test, 215 Congestive heart failure (CHF), 70, 177, 276 - See also Heart disease; Heart failure (HF) CONTAK CD trial, 8, 12, 105-106, 114, 11... - See also CRT trials Contractility, myocardial, 264 - See also Hemodynamic sensors Coronary sinus, inability to cannulate, 411 - See also LV lead placement Coronary stenting, 49 Coronary venoplasty, 46-48 - See also LV pacing Coronary venous system - See also LV lead placement; LV pacing absent or inaccessible target veins, 38-39, 4... - active fixation leads in, 48, 50 - ECG patterns from, 429 - tortuosity, 411 CRT (cardiac resynchronization therapy) - advances, 181-198, 475-491 - algorithms, 188-196 - antibradycardia pacing patients and, 129 - arrhythmias issues, 498-502 - atrial fibrillation (AF) and, 10-11, 113 - automatic optimization of AV and VV delay (CRT advances), 193 - AV block and, 9-10 - AV programmability, 246 - benefits, 148-149 CARE-HF trial, 95-101 clinical practice guidelines, 4 complications, 112, 382 conventional approach, 37-41 - device and lead related issues, 502-504 - device hardware technology, 181-183 - device memory functions, 184-187 - devices programming, 283-284 - for disordered electrical timing, 322-327 - electrocardiogram during, 425-453 - functional (secondary) MR and, 11-12 - functional MR reduction and, 327-329 - guidelines, 4-5 - hardware systems, 330-332 - heart failure (HF) and, 8-10, 123-134, 507-512 - hemodynamic sensors and, 253 - ICD versus, 111 - interventricular interval programmability, 237-239, 244, 246-249 - intraventricular conduction delay and, 123-128 - IVCD and, 12 - latency aspects, 225-227 - LBBB and, 389 - lead dislodgment and loss of, 40-41 - loss, see CRT loss for LV dysfunctioning patients, 30 - LVEF parameters, 118 - nonconventional and alternative approach, 41-56 - NYHA classes, 118 - optimal stimulation site, importance of achieving, 35-37 - in patients with narrow QRS, 11 - possible future expansion of indications, 8- proarrhythmia, 380-381
[weiter lesen] |
|
|
|
|
|
|
| |
|
|

|
|